Amgen, Pfizer Q4
January 30, 2014
Pfizer Inc and Amgen have
reported fourth quarter results,
with Amgen pulling in profit of
US$1b, up 30% year on year.
Revenue rose 13% to US$5b, with
full year up 8% to US$18.7b.
GAAP net income for the full year
was US$5b, up 17% year on year.
Meanwhile Pfizer’s Q4 net income
of US$2.57b, compared with
US$6.32b for the year ago period,
nevertheless beat estimates,
MarketWatch reported.
Sales were US$13.56b compared
with the previous year’s US$13.89b,
with revenues coming in at
US$13.6b, down 2% year on year.
The above article was sent to subscribers in Pharmacy Daily's issue from 30 Jan 14To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 30 Jan 14